Hunter Smith offers a restaurant analogy in trying to illustrate the severe financial squeeze that pharmacy benefit managers ...

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." ...

Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...

The price of CVS stock has increased by 48.80% since Jim Cramer called the overall situation fraught. So, what happened?

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

A federal judge in Missouri rejected three major pharmacy benefit managers’ push to pause the Federal Trade Commission’s ...

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...